Warning
Mae'r hysbyseb swydd hon wedi dod i ben ac mae'r ceisiadau wedi cau.
Healthcare Scientist (Genomics Development) | Manchester University NHS Foundation Trust
| Dyddiad hysbysebu: | 07 Mehefin 2024 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £43,742 - £50,056 Per Annum(Pro Rata) |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 07 Gorffennaf 2024 |
| Lleoliad: | Manchester, M13 9WL |
| Cwmni: | Manchester University NHS Foundation Trust |
| Math o swydd: | Cytundeb |
| Cyfeirnod swydd: | 6295824/349-SMH-6295824 |
Crynodeb
An exciting opportunity has arisen for a Healthcare Scientist to join our team workingwithin the NHS rare and inherited disease NHS genomic network of excellence team in Manchester.
The postholder is expected to be a postdoctoral scientist who will utilise their specialist scientific expertise in genomics. The role will involveworking closely with the teams of the Rare Conditions and Advanced Diagnostics themes of the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) and the University of Manchester (UoM) research group of Prof. Siddharth Banka.
This is a 2 year fixed-term (full-time post) based at the North-West Genomics Laboratory Hub, St. Mary’s Hospital, Manchester.
https://www.manchesterbrc.nihr.ac.uk/our-research/rare-conditions/
https://research.manchester.ac.uk/en/persons/siddharth.banka
https://www.england.nhs.uk/genomics/nhs-genomic-networks-of-excellence/#rare-and-inherited-disease
This role will involve:
Evaluation of published developments and innovations relevant to the Rare & Inherited Disease Network of Excellence, and their potential to transfer into clinical practice.
Evaluation and implementation of new methods, technologies and equipment relevant to the Rare & Inherited Disease Network of Excellence.
Analysis of data from various genomic analysis instruments involving the use of specialist software and relevant bioinformatic tools.
Writing of reports and other documents as the project progresses.
Please refer to the job description and person specification for further details.
Manchester University NHS Foundation Trust (MFT) is one of the largest acute Trusts in the UK, employing over 28,000 staff and is responsible for running a family of ten hospitals across six separate sites. MFT is the main provider of hospital care to approximately 750,000 people in Manchester and Trafford and the single biggest provider of specialised services (which includes Genomic Medicine) in the North-West of England.
The focus of the Rare Disease NHS Genomic Network of Excellence is to (i) help patients get a diagnosis faster (ii) reduce genomic health inequalities (iii) develop new testing approaches (especially for those patients with a suspected rare disease that remain undiagnosed using current NHS genomic testing (iv) increase the efficiency of analysis and (v) increase capacity for rare condition clinical trials.
The Manchester BRC was awarded more than £60 million (2022-27) and is driving forward pioneering research in the areas of high-burden under-researched conditions (rare conditions, hearing health and mental health), disease complexity and multimorbidity (next generation phenotyping and diagnostics, next generation therapeutics), cancer (prevention and early detection, advanced radiotherapy, precision medicine, living with and beyond cancer) and inflammation (rheumatic and musculoskeletal disease, respiratory medicine, dermatology, integrative cardiovascular medicine).
To find out more about the key responsibilities and the specific skills and experience you’ll need, please refer to the Job Description & Person Specification attachments under the ‘Supporting Documents’ heading.
We also recommend that you read the ‘Candidate Essentials Guide’that sits with the Job Description and Person Specification. This document provides you with details about the Trust, our benefits and outlines how ‘we care for you as you care for others’. Most importantly, it also contains critical information you’ll need to be aware of before you submit an application form.
Additional notes:
• Interviews may be in person or online.
• Visiting the laboratory in advance of interview will not normally be possible.
• The NW-GLH operates a 6 day delivery model and therefore new applicants should be aware that they may be required to work a rota pattern to support this, which will include occasional Saturday and Bank Holiday working.
• MFT is currently reviewing the use of AI tools for generating content when applying for jobs. We therefore recommend that candidates do not rely on AI tools when applying for this post.
This advert closes on Friday 21 Jun 2024
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.